mild cognitive impairment, Alzheimer'
Conditions
Interventions
11C-PiB, 18F-FDG PET
Sponsors
Nagoya City Rehabilitation Agency
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Persons who were visited to our hospital and diagnosed with dementia or mild cognitive impairment and given an agreement on the PET study
Exclusion criteria
Exclusion criteria: 1. Persons with other serious illnesses or unstable conditions, 2. Persons suffering from deformities / disorders of spine or hip with pain in resting position, 3. Persons judged inappropriate by doctor or the chief researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Differences in glucose metabolism , degree of accumulation of amyloid, accumulation site of amyloid by disease | — |
Secondary
| Measure | Time frame |
|---|---|
| Relationship between clinical features and glucose metabolism, degree and site of amyloid accumulation | — |
Countries
Japan
Contacts
Public ContactToshihisa Tajima
Nagoya City Rehabilitation Agency Bureau of Planning and Research
Outcome results
None listed